Alexa Fluor® 700 anti-human CD158e1 (KIR3DL1, NKB1)

Antibodies Single
Sony
DX9
Flow Cytometry
Mouse IgG1, κ
Human
Human NK cell clone VL186-1.6
2163555
$145.00

Description

CD158e1, also known as NKB1, is a 70 kD member of the immunoglobulin superfamily that is expressed on a subset of natural killer cells and T cells at varying levels among individuals. NKB1 is a type I membrane protein containing two immunoglobulin C2-type domains. The interaction of NKB1 with specific HLA-B antigens on a target cell (the HLA-Bw4 allele, for example) inhibits cytotoxicity and prevents target cell lysis and death. The interactions between KIR and MHC class I are thought to be important in NK and T cell regulation following antigen stimulation. The absence of ligands for KIRs may lower the threshold for activation through activating receptors and increase inflammation and susceptibility to autoimmune disease.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤0.125 microg per million cells in 100 microL volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.

References

1. Litwin V, et al. 1994. J. Exp. Med. 180:537. (IP)
2. Gumperz J, et al. 1996. J. Exp. Med. 183:1817.
3. Gardiner CM, et al. 2001. J. Immunol. 166:2992.
4. Bakker ABH, et al. 1998. J. Immunol. 160:5239.
5. Goodier M, et al. 2000. J. Immunol. 165:139.
6. Kirwan SE and Burshtyn DN. 2005. J. Immunol. 175:5006. (FC)
7. Yawata M, et al. 2002. Immunogenetics 54:543.
8. Valiante NM, et al. 1997. Immunity 7:739.
9. Pascal V, et al. 2007. J. Immunol. 179:1625. (FC) PubMed
10. Lichterfeld M, et al. 2008. J. Exp. Med. 204:2813. (FC) PubMed
11. Miller JS, et al. 2014. Biol Blood Marrow Transplant. 20:1252. PubMed
12. Cosgrove C, et al. 2014. PLoS One. 9:105950. PubMed